LogoAgentHunter
  • Submit
  • Industries
  • Categories
  • Agency
Logo
LogoAgentHunter

Discover, Compare, and Leverage the Best AI Agents

Featured On

Featured on yo.directory
yo.directory
Featured on yo.directory
Featured on Startup Fame
Startup Fame
Featured on Startup Fame
AIStage
Listed on AIStage
Sprunkid
Featured on Sprunkid
Featured on Twelve Tools
Twelve Tools
Featured on Twelve Tools
Listed on Turbo0
Turbo0
Listed on Turbo0
Featured on Product Hunt
Product Hunt
Featured on Product Hunt
Game Sprunki
Featured on Game Sprunki
AI Toolz Dir
Featured on AI Toolz Dir
Featured on Microlaunch
Microlaunch
Featured on Microlaunch
Featured on Fazier
Fazier
Featured on Fazier
Featured on Techbase Directory
Techbase Directory
Featured on Techbase Directory
backlinkdirs
Featured on Backlink Dirs
Featured on SideProjectors
SideProjectors
Featured on SideProjectors
Submit AI Tools
Featured on Submit AI Tools
AI Hunt
Featured on AI Hunt
Featured on Dang.ai
Dang.ai
Featured on Dang.ai
Featured on AI Finder
AI Finder
Featured on AI Finder
Featured on LaunchIgniter
LaunchIgniter
Featured on LaunchIgniter
Imglab
Featured on Imglab
AI138
Featured on AI138
600.tools
Featured on 600.tools
Featured Tool
Featured on Featured Tool
Dirs.cc
Featured on Dirs.cc
Ant Directory
Featured on Ant Directory
Featured on MagicBox.tools
MagicBox.tools
Featured on MagicBox.tools
Featured on Code.market
Code.market
Featured on Code.market
Featured on LaunchBoard
LaunchBoard
Featured on LaunchBoard
Genify
Featured on Genify
Copyright © 2025 All Rights Reserved.
Product
  • AI Agents Directory
  • AI Agent Glossary
  • Industries
  • Categories
Resources
  • AI Agentic Workflows
  • Blog
  • News
  • Submit
  • Coummunity
  • Ebooks
Company
  • About Us
  • Privacy Policy
  • Terms of Service
  • Sitemap
Friend Links
  • AI Music API
  • ImaginePro AI
  • Dog Names
  • Readdit Analytics
Back to News List

NVIDIA and Novo Nordisk Partner to Advance AI in Drug Discovery

June 11, 2025•Unknown•Original Link•2 minutes
AI
DrugDiscovery
Biomedicine

Stay updated on the latest IT trends in biomedicine including genomics and computational science with recent news on AI-driven drug discovery.

By Bio-IT World Staff
June 11, 2025

NVIDIA CEO Jensen Huang highlighted the limitations of pre-trained generative AI models, such as hallucinations and lack of access to real-time data, during his presentation at NVIDIA GTC in Paris. However, he emphasized that these "one-shot" AI models were essential stepping stones to the development of agentic AI, which he described as a significant leap forward.

Key Announcement: NVIDIA and Novo Nordisk Partnership

NVIDIA announced a collaboration with pharmaceutical giant Novo Nordisk to accelerate drug discovery using customized AI models and agents. This partnership aims to leverage NVIDIA's advanced simulation and physical AI technologies to enhance early research, clinical development, and molecule design.

NVIDIA’s AI Platform for Drug Discovery

Novo Nordisk will utilize the NVIDIA AI Enterprise software platform to build specialized AI agents tailored to pharmaceutical development. According to Rory Kelleher, NVIDIA’s senior director of business development for life sciences, this platform will help Novo Nordisk "harness the full potential of generative and agentic AI."

The collaboration will focus on several AI-driven initiatives, including:

  • Single-cell models to predict cellular responses to drug candidates.
  • Molecule design to create compounds with drug-like properties.
  • Biomedical large language models to analyze global scientific literature and uncover correlations between genes, proteins, and diseases.

Technological Infrastructure

The research will be conducted on Denmark’s flagship AI supercomputer, DCAI’s Gefion, powered by NVIDIA DGX SuperPOD. Novo Nordisk will also employ:

  • NVIDIA BioNeMo for generative AI in drug discovery.
  • NVIDIA NIM and NVIDIA NeMo microservices for building agentic workflows.
  • NVIDIA Omniverse for creating physically accurate simulation environments.

Industry Impact

Mishal Patel, Novo Nordisk’s senior vice president of AI and digital innovation, stated that combining NVIDIA’s computing expertise with Novo Nordisk’s R&D capabilities will enable faster and more efficient drug development. This partnership underscores the growing role of AI in transforming the pharmaceutical industry.

"You’re going to be hiring agents," Huang predicted, envisioning a future where companies rely on specialized AI agents for tasks ranging from market research to operations planning.

This collaboration marks a pivotal moment in the convergence of AI and life sciences, promising to unlock new possibilities in drug discovery and development.

Related News

August 18, 2025•Kaydence Shum

Lenovo Wins Frost Sullivan 2025 Asia-Pacific AI Services Leadership Award

Lenovo earns Frost Sullivan's 2025 Asia-Pacific AI Services Customer Value Leadership Recognition for its value-driven innovation and real-world AI impact.

AI
Lenovo
Asia-Pacific
August 18, 2025•Unknown

Baidu Wenku GenFlow 2.0 Revolutionizes AI Agents with Multi-Agent Architecture

Baidu Wenku's GenFlow 2.0 introduces a multi-agent system for parallel task processing, integrating with Cangzhou OS to enhance efficiency and redefine AI workflows.

AI
MultiAgent
Baidu

About the Author

Dr. Emily Wang

Dr. Emily Wang

AI Product Strategy Expert

Former Google AI Product Manager with 10 years of experience in AI product development and strategy formulation. Led multiple successful AI products from 0 to 1 development process, now provides product strategy consulting for AI startups while writing AI product analysis articles for various tech media outlets.

Expertise

AI Product Management
User Experience
Business Strategy
Market Analysis
Experience
10 years
Publications
65+
Credentials
2
LinkedInMedium

Agent Newsletter

Get Agentic Newsletter Today

Subscribe to our newsletter for the latest news and updates